Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A post hoc Analysis from the Randomized VERTIS CV Trial Article

Open Access Industry Collaboration International Collaboration

cited authors

  • Cherney, David Z. I.; Dagogo-Jack, Samuel; Cosentino, Francesco; Pratley, Richard E.; Frederich, Robert; Maldonado, Mario; Liu, Chih-Chin; Cannon, Christopher P.; VERTIS CV Investigators

Publication Date

  • August 1, 2022

webpage

published in

category

keywords

  • albuminuria
  • diabetic kidney disease
  • ertugliflozin
  • sodium-glucose cotransporter 2 inhibitor
  • type 2 diabetes mellitus

start page

  • 1782

end page

  • 1792

volume

  • 7

issue

  • 8